LAUREN MIZE: Open Payments
NPI 1598414765 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 12 payments from 10 companies in 2025. Trend: 2023 $16 · 2024 $76 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $51 |
| ABBVIE INC. | 2 | $36 |
| Solventum Corporation | 1 | $24 |
| Sage Therapeutics, LLC | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
| Organon LLC | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
| Evofem Biosciences, Inc. | 1 | $4 |
Products named: Veozah, UBRELVY, PREVENA, ZURZUVAE, ZORYVE, Dexcom G6 Transmitter, ACCRUFER, NEXPLANON.
Industry payments across MS — which companies pay providers there.
